Newsroom

OFT statement regarding PPRS

115/07    3 August 2007

The OFT is encouraged by the announcements of both the Department of Health and the Department for Business Enterprise & Regulatory Reform yesterday and the recognition of the OFT's study which highlighted the major benefits to patients and innovative companies which a reform of the Pharmaceutical Price Regulation Scheme (PPRS) could lead to. The OFT believes that replacing the current price and profit controls with a value based approach to pricing will provide value for money for the NHS, better incentives to invest for companies and a more sustainable, stable system. The OFT will continue to actively assist the Department of Health, supporting its move to reform the PPRS.

Back to:2007